Home/Filings/4/0001209191-14-005341
4//SEC Filing

BIODELIVERY SCIENCES INTERNATIONAL INC 4

Accession 0001209191-14-005341

CIK 0001103021operating

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:32 PM ET

Size

20.0 KB

Accession

0001209191-14-005341

Insider Transaction Report

Form 4
Period: 2014-01-24
Finn Andrew L
Executive Vice President
Transactions
  • Exercise/Conversion

    Options

    2014-01-2410,6030 total
    Exercise: $2.05From: 2007-07-27Exp: 2016-07-24Common Stock (10,603 underlying)
  • Exercise/Conversion

    Options

    2014-01-2449,0000 total
    Exercise: $3.03From: 2006-12-01Exp: 2015-12-01Common Stock (49,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-01-24$2.05/sh+10,603$21,736786,256 total
  • Exercise/Conversion

    Common Stock

    2014-01-24$2.94/sh+8,929$26,251795,185 total
  • Exercise/Conversion

    Common Stock

    2014-01-24$3.40/sh+5,147$17,500800,332 total
  • Exercise/Conversion

    Common Stock

    2014-01-24$3.03/sh+49,000$148,470849,332 total
  • Sale

    Common Stock

    2014-01-24$9.03/sh143,679$1,297,421705,653 total
  • Exercise/Conversion

    Options

    2014-01-245,1470 total
    Exercise: $3.40From: 2005-10-21Exp: 2014-10-21Common Stock (5,147 underlying)
  • Exercise/Conversion

    Options

    2014-01-248,9290 total
    Exercise: $2.94From: 2006-07-28Exp: 2015-07-28Common Stock (8,929 underlying)
Footnotes (2)
  • [F1]The sale of the shares of common stock was made pursuant to a 10b5-1 plan.
  • [F2]On January 24, 2014, the Reporting Person sold an aggregate of 143,679 shares of the Issuer's Common Stock at a weighted average price of $9.03. The highest sale price for the Common Stock was $9.30 per share and the lowest sale price was $8.67 per share.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001103021

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:32 PM ET
Size
20.0 KB